T1	Participants 81 131	patients with Stage IV lung and colorectal cancer:
T2	Participants 190 210	patients with cancer
T3	Participants 269 296	those with Stage IV disease
T4	Participants 512 584	Sixty-six adults with Stage IV lung or colorectal cancer were randomized
T5	Participants 1309 1362	RESULTS Three participants dropped out and seven died
T6	Participants 1731 1783	of patients with Stage IV lung and colorectal cancer
